Surprisingly, the potency of temporal Treg Ezh2-deficiency was higher than systemic depletion of Tregs in controlling tumor progression, indicating a potential pro-inflammatory function of Ezh2-deficient Tregs [71]. Here, EZH2 is linked to neoplasm.